AstraZeneca’s Saphnelo (anifrolumab-fnia) was approved in the United States for the treatment of adult patients with moderate to severe systemic lupus erythematosus who are receiving standard therapy.
If you are not happy with the results below please do another search
50 search results for:
The Olympics host city Tokyo, as well as Thailand and Malaysia, announced record Covid-19 infections on July 31, mostly driven by the highly transmissible Delta variant of the disease.
An Illinois jury on July 30 refused to hold Johnson & Johnson liable for a woman’s death from ovarian cancer, which her family blamed on decades of using the company’s talc-based powders.
The U.S. Food and Drug Administration expanded the emergency use authorization of Regeneron Pharmaceuticals Inc.’s Covid-19 antibody cocktail, enabling the combo therapy’s use as a preventive treatment for the illness in certain people.
The U.S. Securities and Exchange Commission halted registrations of U.S. initial public offerings (IPOs) by Chinese companies.
The world is at risk of losing hard-won gains in fighting Covid-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on July 30.
Gilead Sciences will open the doors to the company’s new operations site in North Raleigh, N.C., as part of a business services center expansion. Gilead’s second-quarter 2021 product sales increased 21 percent year-over-year, primarily driven by the Covid-19 antiviral treatment Veklury (remdesivir).
The U.S. Food and Drug Administration rejected Ardelyx Inc.’s chronic kidney disease drug tenapanor by issuing a Complete Response Letter.
Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca’s shot revealed no serious side effects and no subsequent cases of coronavirus among volunteers, the Russian Direct Investment Fund (RDIF) said on July 30.
President Joe Biden on July 29 urged local governments to pay people to get vaccinated against Covid-19, and set new rules requiring federal workers to provide proof of vaccination or face regular testing, mask mandates and travel restrictions.